All posts by: Michael Zand

GenCure Opens BioManufacturing Center for Large-Scale Production of Adult Stem Cells to Support Development of … – GlobeNewswire (press release)

GenCure Opens BioManufacturing Center for Large-Scale Production of Adult Stem Cells to Support Development of …GlobeNewswire (press release)GenCure, a subsidiary of BioBridge Global, today opened the first phase of a new biomanufacturing center desi… Continue reading

Company-sponsored CRISPR clinical trials set to start in 2018 … – EurekAlert (press release)

Research Shows How Alcohol Damages Stem Cell DNA – Sci-News.com

Sci-News.comResearch Shows How Alcohol Damages Stem Cell DNASci-News.comMuch previous research looking at the precise ways in which alcohol causes cancer has been done in cell cultures. But in this new study, the scientists have used mice to show how a… Continue reading

Combinations May Be the Future of Immunotherapy in Ovarian Cancer – Curetoday.com

Bluebird hopes for 3 drug approvals by 2019, including CAR-T and gene therapies – Endpoints News

Endpoints NewsBluebird hopes for 3 drug approvals by 2019, including CAR-T and gene therapiesEndpoints NewsThe FDA already gave the program breakthrough therapy designation. The CAR-T was the star of ASH when blurbird reported extremely high response a… Continue reading

Evidence Builds for Immunotherapy Combos in SCLC – OncLive

OncLiveEvidence Builds for Immunotherapy Combos in SCLCOncLiveIncreasing evidence suggests that immune responses against SCLC cells make immunotherapy a rational approach. Preclinical data show that certain chemotherapeutic regimens may augment the imm… Continue reading

Immunity May Make CRISPR-Based Therapies Ineffective – The Scientist

The ScientistImmunity May Make CRISPR-Based Therapies IneffectiveThe ScientistThe immunity could not only limit the effectiveness of CRISPR, but also “create safety concerns,” the researchers write in the study. However, the problem is mostly limited t… Continue reading